BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3560258)

  • 1. Tissue distribution and excretion of tri-(2-ethylhexyl)trimellitate in rats.
    Martis L; Freid E; Woods E
    J Toxicol Environ Health; 1987; 20(4):357-66. PubMed ID: 3560258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human metabolism and kinetics of tri-(2-ethylhexyl) trimellitate (TEHTM) after oral administration.
    Höllerer C; Becker G; Göen T; Eckert E
    Arch Toxicol; 2018 Sep; 92(9):2793-2807. PubMed ID: 30027468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive monitoring of specific metabolites of tri-(2-ethylhexyl) trimellitate (TEHTM) in urine by column-switching liquid chromatography-tandem mass spectrometry.
    Höllerer C; Göen T; Eckert E
    Anal Bioanal Chem; 2018 Jul; 410(18):4343-4357. PubMed ID: 29687250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of polyvinylchloride plasticizers di(2-ethylhexyl) phthalate and tri(2-ethylhexyl) trimellitate and its degradation products in blood by liquid chromatography-tandem mass spectrometry.
    Eckert E; Müller J; Göen T
    J Chromatogr A; 2015 Sep; 1410():173-80. PubMed ID: 26243703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regioselective ester cleavage of di-(2-ethylhexyl) trimellitates by porcine liver esterase.
    Höllerer C; Becker G; Göen T; Eckert E
    Toxicol In Vitro; 2018 Mar; 47():178-185. PubMed ID: 29180039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in silico approach to study the hormonal activities of the alternative plasticizer tri-(2-ethylhexyl) trimellitate TEHTM and its metabolites.
    Dahbi L; Farce A; Kambia N; Séverin I; Dine T; Moreau E; Sautou V; Chagnon MC
    Arch Toxicol; 2022 Mar; 96(3):899-918. PubMed ID: 35089383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the leachability of di(2-ethylhexyl) phthalate and tri(2-ethylhexyl) trimellitate from haemodialysis tubing.
    Kambia K; Dine T; Azar R; Gressier B; Luyckx M; Brunet C
    Int J Pharm; 2001 Oct; 229(1-2):139-46. PubMed ID: 11604266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isomeric separation and quantitation of di-(2-ethylhexyl) trimellitates and mono-(2-ethylhexyl) trimellitates in blood by LC-MS/MS.
    Höllerer C; Müller J; Göen T; Eckert E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():153-162. PubMed ID: 28735223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 2nd communication: absorption, distribution and excretion after single and consecutive subcutaneous administration in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Tsutsumi S; Harada T; Miyoshi R; Inaba A
    Arzneimittelforschung; 1997 Feb; 47(2):195-200. PubMed ID: 9079240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contamination of platelet storage bags by phthalate esters.
    Labow RS; Tocchi M; Rock G
    J Toxicol Environ Health; 1986; 19(4):591-8. PubMed ID: 3783774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
    Kurebayashi H; Betsui H; Ohno Y
    Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution, excretion, and metabolism of butylbenzyl phthalate in the rat.
    Eigenberg DA; Bozigian HP; Carter DE; Sipes IG
    J Toxicol Environ Health; 1986; 17(4):445-56. PubMed ID: 3959124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.